SpringWorks Therapeutics SWTX 深 滬
等待開盤 09-06 09:30:00 美东时间
46.99
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 46.99
- 總市值 35.41亿
- 52周最高 62.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 28.21
- 委 比 0.00%
- 總股本 7534.90万
- 歷史最高 96.48
- 量 比 0
- 振 幅 0.00%
- 歷史最低 13.60
- 每 手 1
- 風險率 7.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
SpringWorks Therapeutics announced that the European Commission has granted marketing authorization for OGSIVEO® (nirogacestat) as the first and only therapy approved in the EU for the treatment of adults with progressing desmoid tumors requiring systemic treatment. The approval is based on the Phase 3 DeFi trial, which demonstrated significant improvements in progression-free survival (PFS), objective response rate (ORR), and patient-reported ou...
08-18 13:10
传默克集团拟发行40亿美元债券 为收购SpringWorks提供资金
据知情人士透露，德国默克集团(Merck KGaA)计划发行约40亿美元的美国投资级债券，为其对SpringWorks Therapeutics的收购提供资金。
08-12 07:57
Merck KGaA gets EU nod for Ezmekly
Merck KGaA (NYSE:MRK) said that the European Commission approved Ezmekly for treating symptomatic, inoperable plexiform neurofibromas in patients with neurofibromatosis type 1 who are 2 years old and ...
07-19 01:02
SpringWorks Therapeutics Receives EC Conditional Marketing Approval For EZMEKLY In Treating NF1-PN Across Pediatric And Adult Patients
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for
07-19 00:14
Madrigal gains after Rezdiffra patent win
Madrigal Pharmaceuticals (NASDAQ:MDGL) traded higher in the premarket on Wednesday after the company announced a patent win related to its lead asset, Rezdiffra, approved by the FDA in 2024 for a live...
07-16 20:54
California Rep. Gilbert Ray Cisneros Sold Over $28K Worth of SpringWorks Therapeutics Inc Ordinary Shares Stock: Here's What You Should Know
An official report on July 10, 2025 reveals Representative Gilbert Ray Cisneros...
07-11 23:00
SpringWorks Therapeutics Completes Merger and Delisting
Springworks Therapeutics ( ($SWTX) ) just unveiled an update. SpringWorks Thera...
07-01 21:08
SpringWorks Merger with Merck Approved by Shareholders
Springworks Therapeutics ( ($SWTX) ) has shared an announcement. On June 26, 20...
06-27 04:53
Madrigal, Viking among notable gainers after Altimmune’s MASH setback
Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) were among notable gainers on Thursday as Altimmune (NASDAQ:ALT) boosted its rivals after posting a mixed outcome from a mi...
06-27 03:42
